Genetic Variants in Mood Disorders

Mood disorders, including major depressive disorder and bipolar disorder, are among the most heritable psychiatric conditions, with twin studies estimating heritability between 40 % and 80 %. Advances in genomic technologies have revealed a highly polygenic architecture in which hundreds of common single nucleotide polymorphisms (SNPs) each confer small increments of risk. Rare coding variants and structural rearrangements also contribute, particularly in early-onset or treatment-resistant forms. Key biological pathways implicated by these variants include synaptic plasticity, calcium signalling, monoaminergic neurotransmission and regulation of the hypothalamic–pituitary–adrenal axis. Integration of genome-wide association study (GWAS) signals with transcriptomic and epigenomic maps has begun to resolve the cell types and developmental windows most affected, pointing to cortical interneurons and glial populations as critical mediators. Polygenic risk scoring holds promise for stratifying individuals by genetic liability and may in future guide preventive interventions. Nonetheless, gene–environment interplay remains a major source of unexplained variance, underscoring the need for large, diverse cohorts and functional follow-up to translate statistical associations into mechanistic insight.

Research from Nature Portfolio

Recent multi-ancestry GWAS meta-analyses have expanded the catalogue of risk loci for major depressive disorder, identifying novel regions that replicate across European, East Asian and African-ancestry cohorts. Fine-mapping of these signals has prioritised candidate genes involved in synaptic vesicle trafficking and immune modulation. Complementary single-cell transcriptomic studies of post-mortem prefrontal cortex have overlaid GWAS loci onto cell-type-specific expression profiles, revealing that many risk variants modulate gene expression in inhibitory interneurons and oligodendrocyte progenitors. In parallel, functional genomics approaches combining CRISPR-based perturbations with chromatin conformation assays have begun to link non-coding risk variants to their effector genes, illuminating regulatory circuits that influence neuronal excitability and resilience to stress.

Genetic Variants in Mood Disorders publication trend

The graph below shows the total number of articles in genetic variants in mood disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Single nucleotide polymorphism (SNP): A single-base change in the DNA sequence that may affect gene function or regulation.

Genome-wide association study (GWAS): A hypothesis-free method that scans common variants across the genome to identify those associated with a trait or disease.

Polygenic risk score (PRS): A quantitative index of genetic liability, calculated by summing the effects of multiple risk alleles weighted by their GWAS effect sizes.

Linkage disequilibrium (LD): The non-random association of alleles at different loci, used to infer haplotype structure and localise causal variants.

Endophenotype: A measurable biological or behavioural marker that lies on the causal pathway between genes and clinical symptoms, aiding mechanistic elucidation.